Tumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccines
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Tumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccines ; volume:2 ; number:1 ; day:16 ; month:4 ; year:2004 ; pages:1-12 ; date:12.2004
Journal of translational medicine ; 2, Heft 1 (16.4.2004), 1-12, 12.2004
- Urheber
-
Srinivasan, Roopa
- Beteiligte Personen und Organisationen
-
Wolchok, Jedd D.
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-2-12
- URN
-
urn:nbn:de:1111-2016041430160
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Srinivasan, Roopa
- Wolchok, Jedd D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Immunotherapy and vaccines
Prophylactic and therapeutic DNA vaccines against Chagas disease
The role of peptide and DNA vaccines in myeloid leukemia immunotherapy
Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol
Developing anti-tumor vaccines : antigens and antigen-presenting cells
Antitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems
Oncolytic viruses as therapeutic cancer vaccines
Viral vector-based therapeutic HPV vaccines
Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines
Ensuring safety of DNA vaccines
Endoplasmic reticulum stress enhances the antigen-specific T cell immune responses and therapeutic antitumor effects generated by therapeutic HPV vaccines
Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines
Immunotherapy and vaccines
Prophylactic and therapeutic DNA vaccines against Chagas disease
The role of peptide and DNA vaccines in myeloid leukemia immunotherapy
Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol
Developing anti-tumor vaccines : antigens and antigen-presenting cells
Antitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems
Oncolytic viruses as therapeutic cancer vaccines
Viral vector-based therapeutic HPV vaccines
Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines
Ensuring safety of DNA vaccines
Endoplasmic reticulum stress enhances the antigen-specific T cell immune responses and therapeutic antitumor effects generated by therapeutic HPV vaccines
Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines
Immunotherapy and vaccines
Prophylactic and therapeutic DNA vaccines against Chagas disease
The role of peptide and DNA vaccines in myeloid leukemia immunotherapy
Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol
Developing anti-tumor vaccines : antigens and antigen-presenting cells
Antitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems
Oncolytic viruses as therapeutic cancer vaccines
Viral vector-based therapeutic HPV vaccines
Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines
Ensuring safety of DNA vaccines
Endoplasmic reticulum stress enhances the antigen-specific T cell immune responses and therapeutic antitumor effects generated by therapeutic HPV vaccines